CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-19 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −7,563 | 39,938 | ||
| 2021-03-31 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise | +4,000 | 4,000 | ||
| 2021-03-31 | Mara Joseph Anthony Jr Chief Financial Officer | Shares withheld for taxes | −1,178 | $55.55 | $65K | 2,822 |
| 2021-03-31 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise · Restricted Stock Unit | −4,000 | $55.55 | $222K | 12,000 |
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +5,000 | $10.95 | $55K | 27,966 |
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Sale | −5,000 | $50.56 | $253K | 22,966 |
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +8,438 | $10.95 | $92K | 31,404 |
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Sale | −1,820 | $51.00 | $93K | 29,584 |
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +20,000 | $10.95 | $219K | 49,584 |
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Sale | −11,104 | $51.84 | $576K | 38,480 |
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −5,000 | 86,736 | ||
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −20,000 | 66,736 | ||
| 2021-03-30 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −8,438 | 58,298 | ||
| 2021-03-30 | Colangelo Dominick President and CEO | Option exercise | +7,500 | $25.80 | $194K | 175,050 |
| 2021-03-30 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −7,500 | 47,501 | ||
| 2021-03-29 | Colangelo Dominick President and CEO | Sale | −1,010 | $51.36 | $52K | 206,540 |
| 2021-03-29 | Colangelo Dominick President and CEO | Sale | −15,552 | $51.09 | $795K | 190,988 |
| 2021-03-29 | Colangelo Dominick President and CEO | Sale | −10,313 | $50.93 | $525K | 180,675 |
| 2021-03-29 | Colangelo Dominick President and CEO | Sale | −13,125 | $50.94 | $669K | 167,550 |
| 2021-03-19 | Rubino Alan L Director | Option exercise | +5,000 | $45.20 | $226K | 7,644 |
Page 50 of 75 · 1,497 trades